REVIEW ARTICLE
Latex Antigens: Identification and Use in Clinical and Experimental Studies, Including Crossreactivity with Food and Pollen Allergens

https://doi.org/10.1016/S1081-1206(10)63135-3Get rights and content

Learning objectives

The purpose of this review is to introduce the reader to the range of latex allergens that have been identified by polypeptide sequencing. This knowledge is important for the assessment of clinical latex hypersensitivity, including crossreactivity with food and aeroallergens.

Data sources

MEDLINE search and relevant publications and reviews from the English medical literature since 1989.

Results

Of the more than 150 polypeptides in natural latex rubber, 35 or more can act as allergens and are recognized by IgE antibodies in the sera of latex-sensitive subjects. Complete or partial amino acid sequence data have now been obtained for 20 or more allergens, and have facilitated cloning of genes and development of allergen-specific antibodies. In latex-sensitive adults, hevein (Hev b6), rubber elongation factor (Hev b1) and Hev b5 are reported as major allergens, while in children with spina bifida, latex particle proteins are important allergens. Although incomplete, the data for finished latex products indicate that the number as well as diversity of latex antigens are limited compared with the allergen profile of natural rubber latex. Latex allergen sequence data allows epitope mapping, which establishes the molecular basis for understanding crossreactivity between latex, food, and aeroallergens.

Conclusion

The identification of latex allergens is paving the way for studying the molecular basis of immunoreactivity to these proteins, including crossreactivity with food and other allergens. The development of reagents to detect and measure anigen-specific responses will increase diagnostic specificity of allergic reactions to latex products.

REFERENCES (60)

  • HY Yeang et al.

    The 14.6 kd rubber elongation factor (Hev b 1) and 24 kd (Hev b 3) rubber particle proteins are recognized by IgE from patients with spina bifida and latex allergy

    J Allergy Clin Immunol

    (1996)
  • JE Slater et al.

    Afinity purification of latex antigens

    J Allergy Clin Immunol

    (1994)
  • Z Chen et al.

    On the allergenicity of Hev b1 among health care workers and patients with spina bifida allergic to natural rubber latex

    J Allergy and Clin Immunol

    (1997)
  • T Palosuo et al.

    IgE antibodies to 3 purified latex proteins measured by ELISA

    J Allergy Clin Immunol

    (1996)
  • VJ Tomazic et al.

    Characterization of the allergen(s) in latex protein extracts

    J Allergy and Clin Immunol

    (1995)
  • A Mazon et al.

    Factors that influence the presence of symptoms caused by latex allergy in children with spina bifida

    J Allergy Clin Immunol

    (1997)
  • A Akasawa et al.

    Comparison of latex-specific IgE binding among nonammoniated latex, ammoniated latex, and latex glove allergenic extracts by ELISA and immunoblot inhibition

    J Allergy Clin Immunol

    (1996)
  • MC Swanson et al.

    Quantification of occupational latex aeroallergens in a medical center

    J Allergy Clin Immunol

    (1994)
  • D Beezhold et al.

    Measurement of natural rubber proteins in latex glove extracts: comparison of the methods

    Ann Allergy Asthma, and Immunol

    (1996)
  • T Fuchs et al.

    Natural latex, grass pollen, and weed pollen share IgE epitopes

    J Allergy Clin Immunol

    (1997)
  • MF Delbourg et al.

    Hypersensitivity to banana in latex-allergic patients. Identification of two major banana allergens of 33 and 37 kD

    Ann Allergy Asthma Immunol

    (1996)
  • F Lavaud et al.

    Allergens, IgE, mediators, inflammatory mechanisms. Allergy to latex, avocado pear, and banana: Evidence for a 30 kD antigen in immunoblotting

    J Allergy Clin Immunol

    (1995)
  • MJ Van der Veen et al.

    Allergens, IgE, mediators, inflammatory mechanisms. Poor biologic activity of cross-reactive IgE directed to carbohydrate determinants of glycoproteins

    J Allergy Clin Immunol

    (1997)
  • S Shah et al.

    Latex allergy and latex sensitization in children and adolescents with meningocele

    J Allergy Clin Immunol

    (1998)
  • M Raulf-Heimsoth et al.

    Lymphocyte proliferation response to extracts from different latex materials and to the purified latex allergen Hev b 1 (rubber elongation factor)

    J Allergy Clin Immunol

    (1996)
  • JE Slater

    Latex allergy

    J Allergy Clin Immunol

    (1994)
  • JE Slater

    Allergic reactions to natural rubber

    Ann Allergy

    (1992)
  • A Posch et al.

    Latex allergens

    Clin Exp Allergy

    (1998)
  • T Danne et al.

    Prevalence of latex-specific IgE antibodies in atopic and nonatopic children with type I diabetes

    Diabetes Care

    (1997)
  • G Reinheimer et al.

    Prevalence of latex-specific IgE antibodies in patients being evaluated for allergy

    Ann Allergy Asthma Immunol

    (1995)
  • Cited by (34)

    • Latex immunotherapy: State of the art

      2012, Annals of Allergy, Asthma and Immunology
      Citation Excerpt :

      Latex allergy has thus become a relevant health problem for the general population and an occupational hazard for health-related professions.3 The risk of sensitization is higher for housekeeping personnel, gardeners, hairdressers, and especially for health care workers or patients undergoing multiple surgeries, such as children with spina bifida or other congenital malformations (eg, of the urinary tract).1 Liss et al4 performed an epidemiological study on a large number of health care workers (HCW), and found a prevalence of latex positivity of 12.1%, without significant differences among professional categories (physicians, nurses, laboratory workers, therapists, and technicians).

    • Food allergy: A practice parameter

      2006, Annals of Allergy, Asthma and Immunology
    • Síndrome látex-frutas

      2002, Allergologia et Immunopathologia
    View all citing articles on Scopus

    Supported by an unrestricted grant from Zeneca Pharmaceuticals

    View full text